Article Text

Download PDFPDF
Severe proximal myopathy secondary to Hashimoto’s thyroiditis
  1. William Jervis1,
  2. Najeeb Shah1,
  3. Shiva Kumar Mongolu2 and
  4. Thozhukat Sathyapalan3
  1. 1 Endocrinology and Diabetes, Hull Royal Infirmary, Hull, UK
  2. 2 Michael White Center of Diabetes & Endocrinology, Hull Royal Infirmary, Hull, UK
  3. 3 Hull York Medical School, University of Hull, Hull, UK
  1. Correspondence to Dr William Jervis, will-jervis{at}


Muscular symptoms in hypothyroidism are common, including myalgia, fatigue and cramps; however, a significantly raised creatine kinase and muscle weakness are rare. Differential diagnosis of patients presenting with muscle weakness and a raised creatine kinase is wide, and hypothyroidism is rarely considered. We report this case of a 30-year-old female presenting with proximal muscle weakness as her primary symptom, hypothyroid symptoms of 3-month duration and a significantly raised creatine kinase. After ruling out other causes of a raised creatine kinase, thyroxine replacement was commenced, which led to complete resolution of her proximal weakness, myalgia and normalisation of creatine kinase level. This case illustrates severe proximal myopathy can be secondary to hypothyroidism, symptoms can resolve with thyroxine replacement and emphasises the importance of measuring thyroid function in patients with proximal weakness/myalgia and a significantly raised creatine kinase.

  • thyroid disease
  • muscle disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors WJ contributed to writing report, literature search and drafting/revising work. NS contributed to writing report and drafting/revising work. SKM contributed to reviewing literature, drafting/revising work, reviewing final version, managed patient/follow-up, had idea for report and controlled decision to publish/guarantor. TS contributed to drafting/revising work and reviewing final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.